Author Correction: Impact of hormone receptor status and distant recurrence-free interval on survival benefits from trastuzumab in HER2-positive metastatic breast cancer. Issue 1 (December 2018)

• Record Type: Journal Article
• Authors: Yang, Hai-Yuan; Ma, Ding; Liu, Yi-Rong; Hu, Xin; Zhang, Jian; Wang, Zhong-Hua; Di, Gen-Hong; Hu, Xi-Chun; Shao, Zhi-Ming
• Is Part Of: Scientific reports. Volume 8:Issue 1(2018)
• Page Start: 1
• Page End: 2
• Publication Date: 2018-12
• Subjects: Natural history -- Research -- Periodicals; Biology -- Research -- Periodicals; Physical sciences -- Research -- Periodicals; Earth sciences -- Research -- Periodicals; Environmental sciences -- Research -- Periodicals; 502.85
• DOI: 10.1038/s41598-018-32881-6
• Languages: English
• ISSNs: 2045-2322

Abstract

A correction to this article has been published and is linked from the HTML and PDF versions of this paper. The error has not been fixed in the paper.